Juan Cabrera, MD
Geriatric Psychiatry · Evansville, INNPI 1295742377
Payments from drug & device makers
Across 741 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$919
- Alkermes, Inc.$716
- Supernus Pharmaceuticals, Inc.$520
- Corium, LLC$511
- plus $5K from 26 others
What the payments were for
- Food & beverage$10,94399%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 129 | $2,028 |
| AbbVie(2 entities) | 154 | $1,594 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 51 | $919 |
| Alkermes, Inc. | 41 | $716 |
| Supernus Pharmaceuticals, Inc. | 35 | $520 |
| Corium, LLC | 44 | $511 |
| Axsome Therapeutics, Inc. | 33 | $502 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $483 |
| Otsuka America Pharmaceutical, Inc. | 26 | $424 |
| Ironshore Pharmaceuticals Inc. | 17 | $367 |
| Teva Pharmaceuticals USA, Inc. | 15 | $325 |
| Sunovion Pharmaceuticals Inc. | 30 | $282 |
| Almatica Pharma LLC | 13 | $250 |
| Vanda Pharmaceuticals Inc. | 12 | $242 |
| Lundbeck LLC | 11 | $232 |
| Tris Pharma Inc | 11 | $207 |
| Neos Therapeutics, LP | 15 | $199 |
| Collegium Pharmaceutical, Inc. | 13 | $187 |
| Noven Therapeutics, LLC | 9 | $165 |
| Neurocrine Biosciences, Inc. | 8 | $165 |
| Acadia Pharmaceuticals Inc | 7 | $125 |
| Grifols USA, LLC | 4 | $113 |
| Eisai Inc. | 5 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $83 |
| Bausch Health US, LLC | 3 | $54 |
| Alfasigma USA, Inc. | 3 | $52 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Neuronetics, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Indivior Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few geriatric psychiatry providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 12 | $85,855 |
| Invega SustennaPaliperidone Palmitate | 12 | $26,639 |
| LybalviOlanzapine/Samidorphan Malate | 12 | $18,354 |
| VyvanseLisdexamfetamine Dimesylate | 43 | $18,165 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $15,635 |
| TrintellixVortioxetine Hydrobromide | 12 | $11,274 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 122 | $9,646 |
| Bupropion XlBupropion Hcl | 158 | $6,431 |
| Vilazodone Hcl | 56 | $5,578 |
| Aripiprazole | 36 | $3,053 |
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 13 | $2,833 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 59 | $2,634 |
| RitalinMethylphenidate Hcl | 12 | $2,380 |
| Clonazepam | 213 | $2,263 |
| Buspirone Hcl | 118 | $2,169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $125 | $85,85512 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $483 | $29,44055 claims |
| Johnson & JohnsonInvega Sustenna | $2,028 | $26,63912 claims |
| Alkermes, Inc.Lybalvi | $716 | $18,35412 claims |
| Axsome Therapeutics, Inc.Auvelity | $502 | $15,63512 claims |
| Lilly USA, LLCOlanzapine | $33 | $42016 claims |
| Almatica Pharma LLCSertraline Hcl | $250 | $31453 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric psychiatry providers in Indianaon file to place this against a meaningful peer group, so we don't.
Other geriatric psychiatry in Evansville
- James TandyIndianapolis$4K
- Samuel LauEast Chicago$1K
- Kevin MurphyFort Wayne$303
- Hugh SpanglerLebanon$243
- Gary SeltmanGoshen$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.